VMD medicines update - December 2025 | British Equine Veterinary Association
  1. Resources
  2. Education
  3. Career support
  4. Get involved
  5. About us
BEVA Logo
  1. Resources
  2. Education
  3. Career support
  4. Get involved
  5. About us

VMD medicines update - December 2025

News Medicines
16 Jan 2026 BEVA

This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets.

New marketing authorisations

Table 1 shows the new marketing authorisations for December 2025

New Marketing Authorisations

Product name and target species

Active substance

Authorisation Holder, territory, and distribution category

Therapeutic group

 

Food Animals

Pergocoat 0.25 mg Film-Coated Tablets for Horses

Pergolide mesylate

Alfasan Nederland B.V.

 

NI, POM-V

Neurological Agent

See the VMD’s Product Information Database for more information on each of these products. There may be a delay before formal documentation is available for some Northern Ireland products, from the European Medicines Agency.

The timing of the product being placed on the market is an issue for the marketing authorisation holder.

For more information, contact the VMD at postmaster@vmd.gov.uk